Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.45 trillion, total revenue of $4.73 trillion and a weighted average PE ratio of 44.38.
Market Cap
9.45T
Revenue
4.73T
Profits
212.83B
PE Ratio
44.38
Profit Margin
4.50%
Dividend Yield
0.40%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.20T | -0.30% | 3,546,857 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 651.11B | 1.25% | 11,925,381 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 505.89B | 0.94% | 8,769,777 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 329.65B | 0.69% | 15,611,991 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 304.51B | 2.84% | 12,835,776 | 450.06B |
| 6 | NVS | Novartis AG | 287.51B | -0.50% | 2,238,035 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 272.50B | -0.60% | 2,023,122 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 248.08B | -2.79% | 2,360,721 | 47.35B |
| 9 | AMGN | Amgen Inc. | 235.64B | -0.15% | 4,956,767 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 206.43B | -0.06% | 7,589,041 | 30.99B |
| 11 | ABT | Abbott Laboratories | 178.39B | -0.84% | 7,300,848 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 171.34B | -2.70% | 13,068,211 | 50.70B |
| 13 | PFE | Pfizer Inc. | 156.18B | -0.51% | 38,317,290 | 63.62B |
| 14 | DHR | Danaher Corporation | 155.03B | -3.16% | 4,015,646 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 138.33B | -2.01% | 2,700,927 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 130.58B | -1.08% | 1,747,650 | 12.95B |
| 17 | MCK | McKesson Corporation | 123.47B | 0.68% | 869,490 | 418.79B |
| 18 | MDT | Medtronic plc | 122.34B | -0.67% | 9,034,015 | 37.54B |
| 19 | BMY | Bristol-Myers Squibb Company | 120.19B | 0.79% | 12,628,975 | 50.03B |
| 20 | SYK | Stryker Corporation | 118.01B | -0.98% | 2,383,199 | 26.30B |
| 21 | SNY | Sanofi | 111.70B | 1.00% | 4,287,319 | 57.89B |
| 22 | CVS | CVS Health Corporation | 103.43B | 1.00% | 10,729,715 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 99.34B | 3.31% | 1,579,473 | 78.70B |
| 24 | GSK | GSK plc | 96.76B | -0.13% | 2,739,575 | 44.53B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 92.39B | -0.19% | 880,216 | 16.90B |
| 26 | ELV | Elevance Health, Inc. | 85.23B | 1.11% | 2,035,137 | 201.83B |
| 27 | MRNA | Moderna, Inc. | 78.90B | -2.17% | 9,697,804 | 2.53B |
| 28 | CI | The Cigna Group | 71.38B | -0.78% | 2,620,655 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 70.17B | 1.68% | 3,803,593 | 29.86B |
| 30 | COR | Cencora, Inc. | 64.71B | -0.63% | 1,231,590 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 63.06B | 0.17% | 1,978,724 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 60.85B | -2.35% | 15,230,119 | 21.07B |
| 33 | EW | Edwards Lifesciences Corporation | 58.56B | -1.95% | 3,620,923 | 6.67B |
| 34 | ARGX | argenx SE | 58.56B | -1.73% | 249,733 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 57.96B | 0.05% | 1,960,753 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 53.28B | -1.95% | 616,302 | 4.66B |
| 37 | MDLN | Medline Inc. | 48.72B | -2.11% | 9,330,808 | 30.68B |
| 38 | A | Agilent Technologies, Inc. | 48.04B | -2.83% | 1,882,470 | 7.37B |
| 39 | HUM | Humana Inc. | 46.84B | 2.63% | 2,316,776 | 154.19B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 45.77B | 1.79% | 6,809,350 | 17.23B |
| 41 | ONC | BeOne Medicines AG | 44.66B | -2.19% | 356,971 | 6.45B |
| 42 | WAT | Waters Corporation | 43.29B | -3.51% | 1,353,588 | 5.61B |
| 43 | VEEV | Veeva Systems Inc. | 43.10B | 1.26% | 1,602,479 | 3.46B |
| 44 | IQV | IQVIA Holdings Inc. | 40.51B | -1.89% | 1,249,998 | 17.31B |
| 45 | HLN | Haleon plc | 39.77B | 0.22% | 17,963,001 | 14.80B |
| 46 | NTRA | Natera, Inc. | 39.64B | -5.70% | 1,385,613 | 2.91B |
| 47 | RPRX | Royalty Pharma plc | 39.26B | 1.08% | 3,531,606 | 2.62B |
| 48 | BIIB | Biogen Inc. | 36.89B | 1.00% | 1,132,509 | 10.30B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 36.46B | -1.53% | 3,782,499 | 21.64B |
| 50 | ALC | Alcon Inc. | 35.65B | -0.26% | 3,421,094 | 10.98B |
| 51 | RVMD | Revolution Medicines, Inc. | 34.87B | 1.11% | 4,741,920 | 197.56M |
| 52 | MTD | Mettler-Toledo International Inc. | 33.15B | -2.27% | 143,694 | 4.20B |
| 53 | RMD | ResMed Inc. | 33.14B | -0.53% | 1,369,820 | 5.73B |
| 54 | GMAB | Genmab A/S | 32.26B | -1.46% | 2,899,118 | 4.30B |
| 55 | ZTS | Zoetis Inc. | 32.14B | -2.08% | 6,097,890 | 9.49B |
| 56 | CNC | Centene Corporation | 31.58B | -2.74% | 7,009,337 | 180.41B |
| 57 | INSM | Insmed Incorporated | 31.01B | -2.17% | 6,215,878 | 1.52B |
| 58 | LH | Labcorp Holdings Inc. | 29.81B | -0.47% | 890,550 | 14.59B |
| 59 | DXCM | DexCom, Inc. | 29.58B | -1.08% | 4,617,928 | 5.10B |
| 60 | ILMN | Illumina, Inc. | 29.15B | -3.91% | 1,936,098 | 4.54B |
| 61 | DGX | Quest Diagnostics Incorporated | 28.42B | -0.31% | 1,366,024 | 11.84B |
| 62 | PHG | Koninklijke Philips N.V. | 28.33B | -2.19% | 2,420,471 | 20.16B |
| 63 | ROIV | Roivant Sciences Ltd. | 28.01B | -0.78% | 3,970,072 | 41.08M |
| 64 | WST | West Pharmaceutical Services, Inc. | 27.19B | -1.61% | 623,492 | 3.40B |
| 65 | STE | STERIS plc | 24.84B | 0.39% | 823,462 | 6.17B |
| 66 | UTHR | United Therapeutics Corporation | 23.63B | -0.78% | 531,777 | 3.19B |
| 67 | INCY | Incyte Corporation | 23.36B | -1.07% | 1,537,177 | 6.01B |
| 68 | VTRS | Viatris Inc. | 22.50B | -1.26% | 9,274,630 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 20.95B | -0.15% | 705,031 | 22.15B |
| 70 | BNTX | BioNTech SE | 20.07B | -0.52% | 1,710,253 | 2.75B |
| 71 | GH | Guardant Health, Inc. | 19.73B | 0.16% | 2,757,523 | 1.28B |
| 72 | ALNY | Alnylam Pharmaceuticals, Inc. | 19.26B | -2.71% | 2,331,677 | 5.01B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.13B | -0.36% | 2,959,482 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.08B | -3.70% | 236,770 | 2.84B |
| 75 | ASND | Ascendis Pharma A/S | 16.58B | -1.26% | 602,891 | 1.37B |
| 76 | RVTY | Revvity, Inc. | 16.21B | -4.20% | 1,663,176 | 2.94B |
| 77 | EXEL | Exelixis, Inc. | 15.77B | -1.82% | 2,194,229 | 2.50B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.24B | -3.84% | 1,587,288 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.06B | -4.15% | 1,154,334 | 3.98B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 14.81B | -2.75% | 1,478,672 | 945.54M |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 14.78B | -2.62% | 984,644 | 4.72B |
| 82 | SOLV | Solventum Corporation | 14.34B | -1.52% | 658,403 | 8.16B |
| 83 | GKOS | Glaukos Corporation | 14.04B | -0.33% | 1,089,561 | 690.33M |
| 84 | ICLR | ICON Public Limited Company | 13.99B | -1.92% | 735,355 | 8.23B |
| 85 | BAX | Baxter International Inc. | 13.14B | 0.00% | 4,321,684 | 11.61B |
| 86 | EHC | Encompass Health Corporation | 13.11B | 1.04% | 911,930 | 6.34B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 13.09B | -1.84% | 3,311,861 | 15.25B |
| 88 | ELAN | Elanco Animal Health Incorporated | 12.87B | -2.09% | 5,832,973 | 5.15B |
| 89 | PEN | Penumbra, Inc. | 12.58B | -0.28% | 205,407 | 1.56B |
| 90 | SNN | Smith & Nephew plc | 12.55B | 0.00% | 1,231,228 | 6.30B |
| 91 | RDY | Dr. Reddy's Laboratories Limited | 12.51B | 0.40% | 1,747,179 | 3.44B |
| 92 | BMRN | BioMarin Pharmaceutical Inc. | 11.70B | -1.64% | 6,062,667 | 3.66B |
| 93 | TECH | Bio-Techne Corporation | 11.42B | -0.04% | 3,663,183 | 1.23B |
| 94 | COO | The Cooper Companies, Inc. | 11.20B | -2.40% | 2,083,981 | 4.24B |
| 95 | ALGN | Align Technology, Inc. | 10.94B | -2.82% | 1,307,633 | 4.16B |
| 96 | FMS | Fresenius Medical Care AG | 10.62B | 1.54% | 1,339,656 | 22.12B |
| 97 | RGEN | Repligen Corporation | 10.47B | -3.81% | 697,683 | 805.61M |
| 98 | HALO | Halozyme Therapeutics, Inc. | 10.41B | -1.82% | 1,502,744 | 1.80B |
| 99 | UHS | Universal Health Services, Inc. | 10.34B | 2.54% | 908,750 | 18.35B |
| 100 | MOH | Molina Healthcare, Inc. | 10.33B | -2.43% | 800,614 | 42.08B |
| 101 | ENSG | The Ensign Group, Inc. | 10.20B | -0.15% | 252,652 | 5.67B |
| 102 | QGEN | Qiagen N.V. | 10.18B | -0.66% | 2,634,824 | 2.12B |
| 103 | DVA | DaVita Inc. | 10.13B | 3.00% | 730,136 | 14.17B |
| 104 | AVTR | Avantor, Inc. | 10.06B | -1.85% | 12,257,027 | 6.64B |
| 105 | TEM | Tempus AI, Inc. | 9.86B | -9.34% | 7,442,192 | 1.51B |
| 106 | KYMR | Kymera Therapeutics, Inc. | 9.84B | -3.42% | 1,278,323 | 102.24M |
| 107 | BIO | Bio-Rad Laboratories, Inc. | 9.65B | -2.34% | 182,302 | 2.59B |
| 108 | PODD | Insulet Corporation | 9.24B | -2.96% | 1,803,647 | 3.19B |
| 109 | HSIC | Henry Schein, Inc. | 9.23B | -1.51% | 1,308,844 | 13.73B |
| 110 | KRYS | Krystal Biotech, Inc. | 9.15B | -2.19% | 286,699 | 470.03M |
| 111 | ATR | AptarGroup, Inc. | 8.88B | -0.19% | 868,102 | 3.99B |
| 112 | SYRE | Spyre Therapeutics, Inc. | 8.88B | -4.26% | 805,362 | - |
| 113 | TGTX | TG Therapeutics, Inc. | 8.87B | -2.37% | 2,089,093 | 897.76M |
| 114 | GMED | Globus Medical, Inc. | 8.86B | -2.49% | 1,512,519 | 3.14B |
| 115 | MDGL | Madrigal Pharmaceuticals, Inc. | 8.81B | -4.45% | 327,824 | 1.43B |
| 116 | PCVX | Vaxcyte, Inc. | 8.77B | -5.09% | 1,912,018 | - |
| 117 | BRKR | Bruker Corporation | 8.62B | -9.08% | 2,250,887 | 3.51B |
| 118 | HNGE | Hinge Health, Inc. | 8.60B | -2.15% | 1,649,673 | 800.82M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 8.40B | -3.37% | 806,162 | 7.46M |
| 120 | SMMT | Summit Therapeutics Inc. | 7.96B | -5.87% | 7,220,139 | - |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 7.92B | -2.11% | 600,710 | 551.69M |
| 122 | HQY | HealthEquity, Inc. | 7.84B | -2.70% | 741,341 | 1.36B |
| 123 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.79B | -3.80% | 1,502,462 | 280.75M |
| 124 | OSCR | Oscar Health, Inc. | 7.68B | -5.50% | 6,605,936 | 17.47B |
| 125 | ALKS | Alkermes plc | 7.55B | -2.69% | 1,080,914 | 1.75B |
| 126 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.38B | 0.38% | 545,189 | 945.96M |
| 127 | AMRX | Amneal Pharmaceuticals, Inc. | 7.36B | -1.26% | 1,673,212 | 3.20B |
| 128 | GRFS | Grifols, S.A. | 7.18B | -0.61% | 848,269 | 8.63B |
| 129 | CHE | Chemed Corporation | 7.11B | -0.50% | 160,152 | 2.66B |
| 130 | CGON | CG Oncology, Inc. | 7.10B | -2.97% | 1,673,717 | 6.17M |
| 131 | CYTK | Cytokinetics, Incorporated | 7.07B | -1.32% | 1,429,671 | 113.29M |
| 132 | TWST | Twist Bioscience Corporation | 7.04B | -7.44% | 3,379,920 | 459.43M |
| 133 | CORT | Corcept Therapeutics Incorporated | 6.96B | -2.09% | 1,091,120 | 963.65M |
| 134 | PACS | PACS Group, Inc. | 6.93B | 1.49% | 964,450 | 5.71B |
| 135 | BLCO | Bausch + Lomb Corporation | 6.93B | -6.33% | 872,063 | 5.42B |
| 136 | TXG | 10x Genomics, Inc. | 6.81B | -9.72% | 3,230,355 | 618.58M |
| 137 | AXSM | Axsome Therapeutics, Inc. | 6.80B | -4.66% | 770,156 | 865.27M |
| 138 | LNTH | Lantheus Holdings, Inc. | 6.68B | 0.00% | 1,067,788 | 1.56B |
| 139 | IMVT | Immunovant, Inc. | 6.57B | -2.31% | 704,929 | - |
| 140 | ORKA | Oruka Therapeutics, Inc. | 6.50B | -1.80% | 1,977,019 | - |
| 141 | TFX | Teleflex Incorporated | 6.41B | -1.11% | 654,990 | 2.26B |
| 142 | IBRX | ImmunityBio, Inc. | 6.40B | -8.37% | 10,641,767 | 182.57M |
| 143 | KOD | Kodiak Sciences Inc. | 6.34B | -0.75% | 693,120 | - |
| 144 | MIRM | Mirum Pharmaceuticals, Inc. | 6.28B | 0.65% | 1,062,251 | 670.78M |
| 145 | ABVX | ABIVAX Société Anonyme | 6.03B | -9.24% | 14,852,919 | 5.33M |
| 146 | SUPN | Supernus, Inc. | 5.94B | 0.92% | 2,831,327 | 1.37B |
| 147 | SRRK | Scholar Rock Holding Corporation | 5.87B | -4.45% | 2,076,166 | 570.00K |
| 148 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.85B | -5.22% | 3,906,185 | 450.82M |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | -0.03% | 259,757 | 253.83M |
| 150 | RDNT | RadNet, Inc. | 5.49B | 0.29% | 594,202 | 2.38B |
| 151 | HAE | Haemonetics Corporation | 5.47B | -0.17% | 382,954 | 1.38B |
| 152 | CON | Concentra Group Holdings Parent, Inc. | 5.29B | 0.94% | 876,516 | 2.34B |
| 153 | LFST | LifeStance Health Group, Inc. | 5.25B | 3.60% | 5,622,550 | 1.68B |
| 154 | BLTE | Belite Bio, Inc | 5.17B | -15.65% | 1,038,037 | - |
| 155 | DOCS | Doximity, Inc. | 5.13B | -2.97% | 2,380,553 | 661.58M |
| 156 | WAY | Waystar Holding Corp. | 5.10B | -2.10% | 1,526,553 | 1.26B |
| 157 | MMSI | Merit Medical Systems, Inc. | 5.05B | -0.08% | 560,270 | 1.61B |
| 158 | MANE | Veradermics, Incorporated | 5.04B | -3.92% | 374,990 | - |
| 159 | CAI | Caris Life Sciences, Inc. | 5.04B | -5.18% | 4,568,174 | 1.05B |
| 160 | LIVN | LivaNova PLC | 5.00B | -1.46% | 536,657 | 1.51B |
| 161 | LQDA | Liquidia Corporation | 4.90B | -3.88% | 1,691,094 | 621.87M |
| 162 | ERAS | Erasca, Inc. | 4.78B | -4.29% | 11,073,349 | - |
| 163 | DNTH | Dianthus Therapeutics, Inc. | 4.76B | -0.33% | 799,661 | 2.72M |
| 164 | OPCH | Option Care Health, Inc. | 4.73B | -0.06% | 2,951,425 | 5.75B |
| 165 | PTCT | PTC Therapeutics, Inc. | 4.71B | -3.27% | 952,598 | 1.16B |
| 166 | COGT | Cogent Biosciences, Inc. | 4.65B | -3.70% | 2,128,424 | - |
| 167 | SHC | Sotera Health Company | 4.54B | -1.85% | 1,730,989 | 1.23B |
| 168 | ADPT | Adaptive Biotechnologies Corporation | 4.52B | -0.43% | 2,483,129 | 298.01M |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.51B | -2.69% | 1,329,567 | 651.03M |
| 170 | MMED | MiniMed Group, Inc. | 4.50B | -1.54% | 4,577,292 | 3.22B |
| 171 | GRAL | GRAIL, Inc. | 4.46B | -5.33% | 757,992 | 166.60M |
| 172 | IONS | Ionis Pharmaceuticals, Inc. | 4.43B | -2.35% | 3,185,935 | 960.09M |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.37B | -3.07% | 1,186,702 | - |
| 174 | ICUI | ICU Medical, Inc. | 4.31B | -1.84% | 223,429 | 2.18B |
| 175 | BLLN | BillionToOne, Inc. | 4.30B | -0.31% | 819,334 | 436.87M |
| 176 | STVN | Stevanato Group S.p.A. | 4.27B | -1.76% | 752,315 | 1.42B |
| 177 | HTFL | HeartFlow, Inc. | 4.10B | 4.62% | 1,891,023 | 238.66M |
| 178 | DFTX | Definium Therapeutics, Inc. | 3.88B | -3.87% | 3,238,016 | - |
| 179 | CRSP | CRISPR Therapeutics AG | 3.79B | 0.44% | 3,322,561 | 25.17M |
| 180 | TNGX | Tango Therapeutics, Inc. | 3.68B | -4.32% | 1,740,729 | 53.81M |
| 181 | CDNA | CareDx, Inc. | 3.68B | -2.67% | 781,924 | 497.40M |
| 182 | NVST | Envista Holdings Corporation | 3.67B | -1.55% | 2,314,941 | 2.88B |
| 183 | OGN | Organon & Co. | 3.65B | -0.14% | 3,572,874 | 6.10B |
| 184 | XENE | Xenon Pharmaceuticals Inc. | 3.64B | -1.38% | 1,090,782 | 7.50M |
| 185 | TARS | Tarsus Pharmaceuticals, Inc. | 3.60B | -6.00% | 706,751 | 682.20M |
| 186 | RLAY | Relay Therapeutics, Inc. | 3.56B | 1.32% | 3,974,821 | 10.35M |
| 187 | SGRY | Surgery Partners, Inc. | 3.47B | 0.34% | 1,111,603 | 3.36B |
| 188 | PBLS | Parabilis Medicines, Inc. | 3.44B | -0.69% | 1,246,541 | 2.26M |
| 189 | ELVN | Enliven Therapeutics, Inc. | 3.42B | 0.26% | 933,555 | - |
| 190 | HIMS | Hims & Hers Health, Inc. | 3.42B | -8.86% | 16,126,358 | 2.87B |
| 191 | IRON | Disc Medicine, Inc. | 3.42B | -1.27% | 561,636 | - |
| 192 | VRDN | Viridian Therapeutics, Inc. | 3.40B | -4.71% | 1,747,926 | 26.31M |
| 193 | PLSE | Pulse Biosciences, Inc. | 3.35B | 2.57% | 466,798 | 1.49M |
| 194 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.35B | -0.69% | 1,135,831 | -665.00K |
| 195 | ARQT | Arcutis Biotherapeutics, Inc. | 3.33B | -2.98% | 1,290,169 | 508.68M |
| 196 | AXGN | Axogen, Inc. | 3.33B | -1.06% | 875,469 | 266.93M |
| 197 | ACHC | Acadia Healthcare Company, Inc. | 3.22B | 0.38% | 1,917,901 | 3.41B |
| 198 | PRVA | Privia Health Group, Inc. | 3.20B | 1.46% | 1,929,609 | 2.43B |
| 199 | IOVA | Iovance Biotherapeutics, Inc. | 3.19B | -5.61% | 13,732,083 | 378.98M |
| 200 | IRTC | iRhythm Holdings, Inc. | 3.18B | 0.51% | 875,141 | 854.04M |
| 201 | ABCL | AbCellera Biologics Inc. | 3.16B | -7.45% | 4,247,358 | 67.85M |
| 202 | VKTX | Viking Therapeutics, Inc. | 3.16B | -4.14% | 3,653,951 | - |
| 203 | XERS | Xeris Biopharma Holdings, Inc. | 3.10B | 2.11% | 2,857,292 | 368.26M |
| 204 | BHC | Bausch Health Companies Inc. | 3.08B | -3.97% | 3,844,166 | 11.11B |
| 205 | NHC | National HealthCare Corporation | 2.99B | 1.18% | 100,675 | 1.58B |
| 206 | GRDN | Guardian Pharmacy Services, Inc. | 2.97B | 0.58% | 526,696 | 1.46B |
| 207 | TMDX | TransMedics Group, Inc. | 2.96B | -9.33% | 1,588,011 | 727.65M |
| 208 | LEGN | Legend Biotech Corporation | 2.96B | -5.28% | 3,422,836 | 1.36B |
| 209 | DNLI | Denali Therapeutics Inc. | 2.96B | 1.37% | 2,632,241 | 21.38M |
| 210 | ACAD | Acadia Pharmaceuticals Inc. | 2.96B | -2.73% | 1,903,306 | 1.20B |
| 211 | VCEL | Vericel Corporation | 2.94B | -1.27% | 582,337 | 324.17M |
| 212 | ADMA | ADMA Biologics, Inc. | 2.92B | -1.27% | 2,448,064 | 519.15M |
| 213 | TLX | Telix Pharmaceuticals Limited | 2.92B | -3.90% | 269,404 | 890.79M |
| 214 | DYN | Dyne Therapeutics, Inc. | 2.90B | -3.31% | 2,231,064 | - |
| 215 | WRBY | Warby Parker Inc. | 2.87B | -4.19% | 7,173,111 | 934.66M |
| 216 | ATRC | AtriCure, Inc. | 2.82B | 2.37% | 813,130 | 589.80M |
| 217 | SLS | SELLAS Life Sciences Group, Inc. | 2.78B | -8.08% | 15,482,378 | - |
| 218 | PGNY | Progyny, Inc. | 2.63B | 0.73% | 1,107,334 | 1.34B |
| 219 | CELC | Celcuity Inc. | 2.62B | -5.26% | 633,993 | - |
| 220 | XNCR | Xencor, Inc. | 2.50B | -2.21% | 1,220,573 | 200.49M |
| 221 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -2.33% | 1,113,897 | 36.54M |
| 222 | MBX | MBX Biosciences, Inc. | 2.46B | -7.23% | 581,885 | - |
| 223 | AVAH | Aveanna Healthcare Holdings Inc. | 2.40B | 2.90% | 2,170,150 | 2.68B |
| 224 | HCM | HUTCHMED (China) Limited | 2.39B | -1.71% | 32,799 | 549.12M |
| 225 | ZLAB | Zai Lab Limited | 2.36B | -4.06% | 1,442,193 | 441.73M |
| 226 | PBH | Prestige Consumer Healthcare Inc. | 2.35B | 0.06% | 612,366 | 1.17B |
| 227 | NEOG | Neogen Corporation | 2.30B | -2.76% | 3,035,462 | 884.00M |
| 228 | MD | Pediatrix Medical Group, Inc. | 2.30B | 0.94% | 790,975 | 1.96B |
| 229 | UFPT | UFP Technologies, Inc. | 2.25B | -2.70% | 118,535 | 649.52M |
| 230 | RCUS | Arcus Biosciences, Inc. | 2.25B | -1.01% | 1,673,536 | 100.00M |
| 231 | ADUS | Addus HomeCare Corporation | 2.24B | 1.18% | 254,340 | 1.50B |
| 232 | PHVS | Pharvaris N.V. | 2.21B | -1.20% | 463,996 | - |
| 233 | PRGO | Perrigo Company plc | 2.21B | -0.62% | 2,175,561 | 4.09B |
| 234 | NAMS | NewAmsterdam Pharma Company N.V. | 2.21B | -5.64% | 1,744,837 | 25.94M |
| 235 | CLDX | Celldex Therapeutics, Inc. | 2.15B | -1.93% | 1,715,751 | 158.00K |
| 236 | LKFT | Lakefront Biotherapeutics NV | 2.14B | -0.24% | 162,486 | 1.13B |
| 237 | ARDT | Ardent Health, Inc. | 2.13B | 4.00% | 1,541,031 | 6.45B |
| 238 | BKD | Brookdale Senior Living Inc. | 2.12B | 1.96% | 6,710,678 | 2.86B |
| 239 | PVLA | Palvella Therapeutics, Inc. | 2.09B | -2.00% | 192,667 | - |
| 240 | BEAM | Beam Therapeutics Inc. | 2.08B | -0.19% | 3,886,508 | 146.64M |
| 241 | RGC | Regencell Bioscience Holdings Limited | 2.07B | -4.13% | 111,054 | - |
| 242 | ESTA | Establishment Labs Holdings Inc. | 2.06B | -0.68% | 464,234 | 264.03M |
| 243 | VCYT | Veracyte, Inc. | 2.03B | 0.36% | 2,792,904 | 581.78M |
| 244 | CLOV | Clover Health Investments, Corp. | 2.00B | -1.06% | 7,250,268 | 2.74B |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -1.28% | 1,341,412 | 321.74M |
| 246 | NEO | NeoGenomics, Inc. | 1.92B | -1.79% | 1,177,080 | 787.75M |
| 247 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | -1.18% | 582,620 | 989.36M |
| 248 | LYCA | Lycia Therapeutics, Inc. | 1.91B | 4.09% | 422,136 | 4.44M |
| 249 | TRVI | Trevi Therapeutics, Inc. | 1.90B | -2.70% | 2,072,101 | - |
| 250 | AZTA | Azenta, Inc. | 1.88B | -4.86% | 621,109 | 621.70M |
| 251 | BHVN | Biohaven Ltd. | 1.87B | -9.23% | 2,394,680 | - |
| 252 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.86B | -1.37% | 3,849,665 | 961.51M |
| 253 | IMNM | Immunome, Inc. | 1.85B | -5.54% | 1,056,097 | 4.02M |
| 254 | VERA | Vera Therapeutics, Inc. | 1.84B | -4.86% | 1,372,403 | 10.28M |
| 255 | ALMR | Alamar Biosciences, Inc. | 1.84B | -7.67% | 712,562 | 114.05M |
| 256 | COAG | Hemab Therapeutics Holdings, Inc. | 1.84B | -1.43% | 347,014 | - |
| 257 | SEPN | Septerna, Inc. | 1.84B | -1.51% | 374,237 | 96.27M |
| 258 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.81B | -2.92% | 1,785,365 | 213.00M |
| 259 | REPL | Replimune Group, Inc. | 1.81B | -0.83% | 1,964,451 | - |
| 260 | ZYME | Zymeworks Inc. | 1.80B | -2.68% | 738,811 | 265.97M |
| 261 | FTRE | Fortrea Holdings Inc. | 1.79B | -7.94% | 1,542,110 | 2.67B |
| 262 | ETON | Eton Pharmaceuticals, Inc. | 1.76B | -0.83% | 562,609 | 141.06M |
| 263 | STOK | Stoke Therapeutics, Inc. | 1.75B | -0.45% | 615,748 | 28.21M |
| 264 | TRAX | First Tracks Biotherapeutics, Inc. | 1.75B | -6.34% | 504,327 | - |
| 265 | SDGR | Schrödinger, Inc. | 1.72B | -12.95% | 1,877,129 | 269.20M |
| 266 | MAZE | Maze Therapeutics, Inc. | 1.72B | -3.27% | 818,927 | 20.00M |
| 267 | KRSA | Korsana Biosciences, Inc. | 1.71B | 5.95% | 265,233 | - |
| 268 | LMAT | LeMaitre Vascular, Inc. | 1.68B | -1.67% | 313,546 | 269.36M |
| 269 | RARE | Ultragenyx Pharmaceutical Inc. | 1.67B | -4.30% | 3,010,190 | 730.00M |
| 270 | TRLV | Trulieve Cannabis Corp. | 1.67B | -7.17% | 1,712,247 | 1.08B |
| 271 | HCSG | Healthcare Services Group, Inc. | 1.67B | -0.20% | 551,899 | 1.88B |
| 272 | BRVE | Braveheart Bio, Inc. | 1.66B | 5.81% | 866,495 | - |
| 273 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | -4.03% | 776,163 | 140.84M |
| 274 | XRAY | DENTSPLY SIRONA Inc. | 1.64B | -2.36% | 4,879,931 | 3.58B |
| 275 | ZBIO | Zenas BioPharma, Inc. | 1.62B | -4.75% | 579,893 | 11.00M |
| 276 | CERT | Certara, Inc. | 1.61B | -1.22% | 2,781,224 | 425.76M |
| 277 | INSP | Inspire Medical Systems, Inc. | 1.60B | -2.10% | 552,318 | 880.94M |
| 278 | PSNL | Personalis, Inc. | 1.55B | -3.06% | 3,335,604 | 80.77M |
| 279 | RXRX | Recursion Pharmaceuticals, Inc. | 1.53B | -9.93% | 29,877,224 | 68.23M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.52B | -0.57% | 644,331 | 593.56M |
| 281 | AGL | agilon health, inc. | 1.52B | 0.83% | 266,326 | 6.00B |
| 282 | PGEN | Precigen, Inc. | 1.51B | 1.20% | 6,069,718 | 156.94M |
| 283 | OMCL | Omnicell, Inc. | 1.50B | -2.02% | 564,518 | 1.24B |
| 284 | KMTS | Kestra Medical Technologies, Ltd. | 1.50B | -5.75% | 435,036 | 106.73M |
| 285 | ASTH | Astrana Health, Inc. | 1.48B | 0.77% | 440,984 | 3.91B |
| 286 | ALVO | Alvotech | 1.47B | -3.96% | 826,672 | 492.31M |
| 287 | ENOV | Enovis Corporation | 1.47B | -2.90% | 1,220,303 | 2.31B |
| 288 | MESO | Mesoblast Limited | 1.46B | -2.59% | 192,701 | 120.25M |
| 289 | ANIP | ANI Pharmaceuticals, Inc. | 1.45B | -0.84% | 227,263 | 1.04B |
| 290 | BFLY | Butterfly Network, Inc. | 1.44B | -7.69% | 4,118,549 | 123.26M |
| 291 | DMRA | Damora Therapeutics, Inc. | 1.44B | -4.44% | 643,366 | - |
| 292 | VIR | Vir Biotechnology, Inc. | 1.44B | -5.41% | 3,089,841 | 302.80M |
| 293 | USPH | U.S. Physical Therapy, Inc. | 1.43B | 1.71% | 209,707 | 829.86M |
| 294 | KLRA | Kailera Therapeutics, Inc. | 1.43B | -4.84% | 553,329 | - |
| 295 | SRPT | Sarepta Therapeutics, Inc. | 1.43B | -5.93% | 2,253,865 | 1.96B |
| 296 | ADRX | ADARx Pharmaceuticals, Inc. | 1.42B | -9.68% | 708,674 | 6.79M |
| 297 | PRCT | PROCEPT BioRobotics Corporation | 1.42B | -4.08% | 1,037,664 | 352.31M |
| 298 | WWB | Windward Bio Group AG | 1.41B | 1.15% | 158,586 | - |
| 299 | NRIX | Nurix Therapeutics, Inc. | 1.40B | -5.51% | 2,433,656 | 701.94M |
| 300 | NTLA | Intellia Therapeutics, Inc. | 1.40B | 5.04% | 15,194,229 | 52.89M |
| 301 | TYRA | Tyra Biosciences, Inc. | 1.39B | 1.98% | 467,576 | - |
| 302 | CNMD | CONMED Corporation | 1.39B | 0.39% | 384,324 | 1.37B |
| 303 | ANAB | AnaptysBio, Inc. | 1.39B | -1.62% | 432,444 | 60.04M |
| 304 | AMN | AMN Healthcare Services, Inc. | 1.38B | 3.87% | 817,962 | 3.52B |
| 305 | RAPP | Rapport Therapeutics, Inc. | 1.37B | -1.82% | 437,695 | 20.00M |
| 306 | LMRI | Lumexa Imaging Holdings, Inc. | 1.37B | 1.42% | 442,423 | 1.06B |
| 307 | IMCR | Immunocore Holdings plc | 1.36B | -0.83% | 546,182 | 429.30M |
| 308 | WGS | GeneDx Holdings Corp. | 1.36B | -7.68% | 912,292 | 460.78M |
| 309 | TDOC | Teladoc Health, Inc. | 1.36B | -4.36% | 4,707,935 | 2.47B |
| 310 | NBTX | Nanobiotix S.A. | 1.36B | -3.00% | 125,283 | 13.15M |
| 311 | QURE | uniQure N.V. | 1.36B | -4.35% | 2,104,181 | 20.17M |
| 312 | URGN | UroGen Pharma Ltd. | 1.36B | -12.86% | 2,399,079 | 250.25M |
| 313 | PAHC | Phibro Animal Health Corporation | 1.35B | -2.32% | 155,535 | 1.54B |
| 314 | NUVB | Nuvation Bio Inc. | 1.34B | -0.26% | 6,848,900 | 201.73M |
| 315 | ALHC | Alignment Healthcare, Inc. | 1.33B | -2.00% | 5,011,606 | 4.94B |
| 316 | INVA | Innoviva, Inc. | 1.31B | 0.00% | 1,146,539 | 438.32M |
| 317 | ABSI | Absci Corporation | 1.30B | -7.97% | 4,747,312 | 1.49M |
| 318 | AVLN | Avalyn Pharma Inc. | 1.26B | -1.05% | 214,298 | - |
| 319 | LBRX | LB Pharmaceuticals Inc | 1.26B | -2.97% | 303,055 | - |
| 320 | NVCR | NovoCure Limited | 1.25B | 0.19% | 1,639,202 | 725.39M |
| 321 | INNV | InnovAge Holding Corp. | 1.25B | 2.81% | 498,365 | 1.02B |
| 322 | MNKD | MannKind Corporation | 1.24B | -2.53% | 4,178,914 | 413.37M |
| 323 | NVAX | Novavax, Inc. | 1.23B | -3.24% | 4,735,225 | 411.65M |
| 324 | SLN | Silence Therapeutics plc | 1.23B | 0.00% | 399,144 | 456.00K |
| 325 | GENB | Generate Biomedicines, Inc. | 1.23B | -8.00% | 967,855 | 21.07M |
| 326 | OCUL | Ocular Therapeutix, Inc. | 1.23B | -4.95% | 2,895,412 | 50.38M |
| 327 | TNDM | Tandem Diabetes Care, Inc. | 1.22B | 3.93% | 2,671,924 | 1.08B |
| 328 | PNTG | The Pennant Group, Inc. | 1.22B | 1.61% | 444,527 | 1.17B |
| 329 | STAA | STAAR Surgical Company | 1.22B | -3.24% | 585,629 | 328.27M |
| 330 | TSHA | Taysha Gene Therapies, Inc. | 1.21B | -1.33% | 3,150,764 | 5.49M |
| 331 | MLYS | Mineralys Therapeutics, Inc. | 1.21B | -3.53% | 1,345,606 | - |
| 332 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.20B | 0.50% | 498,484 | 745.79M |
| 333 | GHRS | GH Research PLC | 1.20B | -5.55% | 298,805 | - |
| 334 | VOR | Vor Biopharma Inc. | 1.18B | 3.62% | 1,555,129 | - |
| 335 | OPK | OPKO Health, Inc. | 1.17B | -2.48% | 3,518,149 | 654.10M |
| 336 | GPCR | Structure Therapeutics Inc. | 1.15B | -5.78% | 786,228 | - |
| 337 | SVRA | Savara Inc. | 1.15B | -18.23% | 17,083,772 | - |
| 338 | HROW | Harrow, Inc. | 1.14B | -5.35% | 911,781 | 303.25M |
| 339 | CMPS | COMPASS Pathways plc | 1.14B | -6.94% | 6,089,163 | - |
| 340 | CRON | Cronos Group Inc. | 1.12B | -1.30% | 1,916,743 | 206.20M |
| 341 | NUTX | Nutex Health Inc. | 1.12B | 0.33% | 157,522 | 796.53M |
| 342 | AAPG | Ascentage Pharma Group International | 1.10B | -3.78% | 5,039 | 94.61M |
| 343 | DRTS | Alpha Tau Medical Ltd. | 1.09B | 3.93% | 628,875 | - |
| 344 | KARD | Kardigan, Inc. | 1.08B | -7.83% | 459,244 | - |
| 345 | AHG | Akso Health Group | 1.08B | -1.56% | 8,564 | 13.83M |
| 346 | SIBN | SI-BONE, Inc. | 1.07B | -0.08% | 801,078 | 220.65M |
| 347 | CBLL | CeriBell, Inc. | 1.06B | 6.37% | 655,908 | 108.72M |
| 348 | JBIO | Jade Biosciences, Inc. | 1.06B | 1.66% | 1,021,381 | - |
| 349 | FRNM | Freenome, Inc. | 1.04B | -5.74% | 621,724 | 217.86M |
| 350 | ATEC | Alphatec Holdings, Inc. | 1.04B | -3.19% | 3,047,382 | 839.72M |
| 351 | IRMD | IRADIMED CORPORATION | 1.04B | -0.30% | 101,300 | 89.34M |
| 352 | NKTR | Nektar Therapeutics | 1.03B | -7.19% | 1,017,697 | 52.19M |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.03B | -2.21% | 828,614 | 1.66B |
| 354 | INBX | Inhibrx Biosciences, Inc. | 1.02B | -7.21% | 252,126 | 2.00M |
| 355 | SGP | SpyGlass Pharma, Inc. | 1.02B | -1.14% | 108,907 | - |
| 356 | ANRO | Alto Neuroscience, Inc. | 1.02B | -4.30% | 522,538 | - |
| 357 | CSTL | Castle Biosciences, Inc. | 1.01B | -1.65% | 309,215 | 377.13M |
| 358 | GDRX | GoodRx Holdings, Inc. | 996.14M | -3.31% | 2,006,632 | 785.23M |
| 359 | OMER | Omeros Corporation | 983.66M | -5.71% | 2,019,784 | 74.36M |
| 360 | SPTX | Seaport Therapeutics, Inc. | 966.23M | -1.47% | 284,271 | - |
| 361 | AHCO | AdaptHealth Corp. | 961.85M | -0.69% | 1,073,418 | 3.44B |
| 362 | CTY | City Therapeutics, Inc. | 961.30M | 5.29% | 250,121 | 14.34M |
| 363 | MLTX | MoonLake Immunotherapeutics | 942.13M | 0.36% | 1,694,554 | - |
| 364 | GMRS | GMR Solutions Inc. | 914.83M | 1.10% | 955,585 | 5.97B |
| 365 | AKTS | Aktis Oncology, Inc. | 901.14M | -1.52% | 374,943 | 12.39M |
| 366 | AORT | Artivion, Inc. | 886.02M | -2.00% | 642,096 | 481.88M |
| 367 | IMTX | Immatics N.V. | 878.58M | -3.03% | 746,739 | 49.33M |
| 368 | LTGO | Latigo Biotherapeutics, Inc. | 861.89M | -1.81% | 267,166 | - |
| 369 | PHAR | Pharming Group N.V. | 840.43M | -5.18% | 10,505 | 386.75M |
| 370 | BVS | Bioventus Inc. | 832.50M | -0.70% | 612,429 | 585.64M |
| 371 | KIDS | OrthoPediatrics Corp. | 828.75M | -2.37% | 153,114 | 264.14M |
| 372 | CRVS | Corvus Pharmaceuticals, Inc. | 815.69M | -3.40% | 927,500 | - |
| 373 | BBTX | Bambusa Therapeutics, Inc. | 815.08M | 2.89% | 137,667 | - |
| 374 | ODTX | Odyssey Therapeutics, Inc. | 813.08M | -7.52% | 677,842 | 99.00K |
| 375 | HSTM | HealthStream, Inc. | 805.34M | 0.19% | 200,036 | 327.95M |
| 376 | CTKB | Cytek Biosciences, Inc. | 800.40M | -3.16% | 1,765,920 | 207.65M |
| 377 | VSTM | Verastem, Inc. | 797.67M | -7.73% | 3,248,798 | 100.30M |
| 378 | SNDX | Syndax Pharmaceuticals, Inc. | 785.05M | -4.49% | 2,182,538 | 289.68M |
| 379 | MGTX | MeiraGTx Holdings plc | 779.89M | -1.97% | 1,013,977 | 401.91M |
| 380 | IRWD | Ironwood Pharmaceuticals, Inc. | 778.09M | -0.21% | 3,021,738 | 400.30M |
| 381 | MTRI | Mentari Therapeutics, Inc. | 776.36M | -3.61% | 85,123 | - |
| 382 | COLL | Collegium Pharmaceutical, Inc. | 768.18M | -1.94% | 527,935 | 815.19M |
| 383 | ORIC | ORIC Pharmaceuticals, Inc. | 764.94M | -4.42% | 1,455,496 | - |
| 384 | VREX | Varex Imaging Corporation | 762.88M | -0.22% | 620,443 | 865.00M |
| 385 | IVA | Inventiva S.A. | 761.40M | -8.99% | 3,023,100 | 2.81M |
| 386 | RIGL | Rigel Pharmaceuticals, Inc. | 754.89M | -2.67% | 352,228 | 288.21M |
| 387 | ARDX | Ardelyx, Inc. | 751.60M | -2.29% | 6,201,119 | 468.22M |
| 388 | OBX | Obsidian Therapeutics, Inc. | 741.27M | -1.23% | 336,484 | - |
| 389 | GLUE | Monte Rosa Therapeutics, Inc. | 738.29M | -3.03% | 2,520,421 | 70.33M |
| 390 | OMDA | Omada Health, Inc. | 736.39M | -5.04% | 1,711,511 | 333.04M |
| 391 | BBNX | Beta Bionics, Inc. | 726.34M | 0.30% | 960,306 | 127.27M |
| 392 | AURA | Aura Biosciences, Inc. | 714.99M | -1.58% | 791,132 | - |
| 393 | INMD | InMode Ltd. | 713.91M | -2.20% | 707,556 | 373.60M |
| 394 | PHR | Phreesia, Inc. | 708.23M | -3.88% | 1,150,641 | 507.79M |
| 395 | SLDB | Solid Biosciences Inc. | 697.57M | -2.95% | 1,558,939 | - |
| 396 | ATTO | Attovia Therapeutics, Inc. | 690.26M | -3.08% | 372,219 | 1.44M |
| 397 | LXRX | Lexicon Pharmaceuticals, Inc. | 681.21M | -8.38% | 4,205,942 | 38.54M |
| 398 | OABI | OmniAb, Inc. | 679.71M | -7.36% | 1,898,284 | 40.21M |
| 399 | FLGT | Fulgent Genetics, Inc. | 673.89M | -2.66% | 322,917 | 330.28M |
| 400 | APMD | Apnimed, Inc. | 669.84M | -6.72% | 248,546 | 108.80M |
| 401 | NVCT | Nuvectis Pharma, Inc. | 666.80M | -2.27% | 301,603 | - |
| 402 | DCTH | Delcath Systems, Inc. | 653.67M | -2.34% | 592,121 | 109.96M |
| 403 | SGMT | Sagimet Biosciences Inc. | 648.02M | -5.61% | 1,501,037 | - |
| 404 | KURA | Kura Oncology, Inc. | 634.88M | -5.99% | 1,752,373 | 79.31M |
| 405 | PRME | Prime Medicine, Inc. | 633.49M | -7.55% | 6,134,377 | 7.06M |
| 406 | IAM | Iambic Therapeutics, Inc. | 621.42M | -8.06% | 285,256 | 24.91M |
| 407 | JANX | Janux Therapeutics, Inc. | 616.73M | -2.04% | 1,114,707 | 23.29M |
| 408 | ABUS | Arbutus Biopharma Corporation | 616.24M | -1.23% | 2,993,383 | 181.49M |
| 409 | OLMA | Olema Oncology, Inc. | 615.00M | -1.82% | 1,256,468 | - |
| 410 | QUIT | Achieve Life Sciences, Inc. | 611.79M | -5.28% | 1,926,847 | - |
| 411 | ZOAR | Zoar Limited | 608.40M | -22.48% | - | - |
| 412 | ANNX | Annexon, Inc. | 591.37M | -9.09% | 4,457,145 | - |
| 413 | IMMX | Immix Biopharma, Inc. | 583.33M | -1.14% | 1,572,776 | - |
| 414 | DSGN | Design Therapeutics, Inc. | 577.61M | -3.22% | 281,931 | - |
| 415 | CGEM | Cullinan Therapeutics, Inc. | 577.15M | -1.98% | 1,010,538 | - |
| 416 | FDMT | 4D Molecular Therapeutics, Inc. | 576.76M | -4.57% | 690,939 | 96.06M |
| 417 | ENTX | Entera Bio Ltd. | 575.53M | 0.76% | 469,047 | 42.00K |
| 418 | TCMD | Tactile Systems Technology, Inc. | 573.48M | -1.50% | 239,291 | 356.42M |
| 419 | DBVT | DBV Technologies S.A. | 571.97M | -4.25% | 156,494 | 3.74M |
| 420 | QDEL | QuidelOrtho Corporation | 570.86M | -6.73% | 2,609,851 | 2.59B |
| 421 | SGHT | Sight Sciences, Inc. | 565.79M | -4.14% | 369,594 | 88.40M |
| 422 | GERN | Geron Corporation | 560.94M | -4.63% | 13,833,298 | 217.52M |
| 423 | BCAX | Bicara Therapeutics Inc. | 560.31M | -7.46% | 814,505 | - |
| 424 | CBIO | Crescent Biopharma, Inc. | 556.41M | 0.70% | 422,370 | 15.00M |
| 425 | ANL | Adlai Nortye Group Ltd. | 550.60M | -5.63% | 380,645 | 18.06M |
| 426 | ACRS | Aclaris Therapeutics, Inc. | 545.63M | -1.71% | 2,187,514 | 6.40M |
| 427 | AVBP | ArriVent BioPharma, Inc. | 544.13M | -6.57% | 1,053,365 | 5.00M |
| 428 | SRZN | Surrozen, Inc. | 542.49M | -7.21% | 148,847 | 10.53M |
| 429 | CLYM | Climb Bio, Inc. | 539.80M | -0.97% | 770,168 | - |
| 430 | NRC | NRC Health | 533.93M | 0.68% | 88,910 | 143.79M |
| 431 | SOPH | SOPHiA GENETICS SA | 533.65M | -6.74% | 827,640 | 90.97M |
| 432 | MYGN | Myriad Genetics, Inc. | 523.74M | -1.44% | 1,248,897 | 803.60M |
| 433 | ZVRA | Zevra Therapeutics, Inc. | 521.26M | -3.42% | 1,152,979 | 147.76M |
| 434 | OBIO | Orchestra BioMed Holdings, Inc. | 517.88M | -6.00% | 554,263 | 31.21M |
| 435 | ALMS | Alumis Inc. | 514.09M | -8.55% | 1,794,569 | 7.24M |
| 436 | PACB | Pacific Biosciences of California, Inc. | 510.07M | -7.39% | 13,692,575 | 161.39M |
| 437 | ETRA | Electra Therapeutics, Inc. | 509.04M | -9.28% | 376,121 | - |
| 438 | WVE | Wave Life Sciences, Inc. | 504.91M | -5.88% | 2,283,405 | 70.92M |
| 439 | RCEL | AVITA Medical, Inc. | 494.96M | -2.31% | 386,957 | 84.68M |
| 440 | VALN | Valneva SE | 493.60M | -3.91% | 17,550 | 163.30M |
| 441 | EVO | Evotec SE | 489.06M | -8.97% | 77,587 | 815.72M |
| 442 | AVR | Anteris Technologies Global Corp. | 486.49M | -1.96% | 1,537,986 | 2.33M |
| 443 | DNA | Ginkgo Bioworks Holdings, Inc. | 483.54M | -9.02% | 2,510,975 | 130.75M |
| 444 | TKNO | Alpha Teknova, Inc. | 479.95M | -2.30% | 254,648 | 45.95M |
| 445 | CARL | Carlsmed, Inc. | 477.38M | 1.16% | 261,682 | 71.78M |
| 446 | SANA | Sana Biotechnology, Inc. | 476.42M | -8.62% | 4,458,957 | - |
| 447 | RGNX | REGENXBIO Inc. | 473.44M | -0.28% | 1,062,394 | 153.91M |
| 448 | MNPR | Monopar Therapeutics Inc. | 467.60M | -1.84% | 132,610 | - |
| 449 | FENC | Fennec Pharmaceuticals Inc. | 462.14M | -2.68% | 398,244 | 66.37M |
| 450 | GYRE | Gyre Therapeutics, Inc. | 460.79M | -6.86% | 240,135 | 110.06M |
| 451 | NGNE | Neurogene Inc. | 458.53M | -3.40% | 178,263 | 925.00K |
| 452 | BLSM | BlossomHill Therapeutics, Inc. | 458.29M | 0.69% | 270,735 | - |
| 453 | KMDA | Kamada Ltd. | 455.78M | -1.15% | 84,304 | 196.87M |
| 454 | ANGO | AngioDynamics, Inc. | 454.61M | 0.46% | 430,544 | 325.38M |
| 455 | ASMB | Assembly Biosciences, Inc. | 454.39M | -1.38% | 480,919 | 67.01M |
| 456 | STTK | Shattuck Labs, Inc. | 454.22M | -1.98% | 1,031,180 | 1.00M |
| 457 | HELP | Helus Pharma Inc. | 446.40M | -9.88% | 2,505,237 | - |
| 458 | DMAC | DiaMedica Therapeutics Inc. | 445.15M | 2.87% | 313,542 | - |
| 459 | MDXG | MiMedx Group, Inc. | 445.07M | -1.93% | 2,120,137 | 303.73M |
| 460 | CTMX | CytomX Therapeutics, Inc. | 442.55M | -0.98% | 4,868,683 | 14.03M |
| 461 | CAPR | Capricor Therapeutics, Inc. | 441.30M | 0.80% | 20,056,476 | 11.13M |
| 462 | EVH | Evolent Health, Inc. | 441.11M | 13.70% | 4,418,845 | 2.34B |
| 463 | SENS | Senseonics Holdings, Inc. | 439.34M | -9.99% | 1,394,280 | 60.01M |
| 464 | OCS | Oculis Holding AG | 435.83M | -5.11% | 235,174 | 1.12M |
| 465 | AQST | Aquestive Therapeutics, Inc. | 434.88M | -6.61% | 3,360,585 | 48.84M |
| 466 | INDP | Indaptus Therapeutics, Inc. | 433.10M | -9.90% | 239,359 | - |
| 467 | IRLA | IRulya Therapeutics Inc. | 432.36M | -0.15% | 200,561 | - |
| 468 | EOLS | Evolus, Inc. | 431.55M | -6.86% | 813,527 | 325.47M |
| 469 | ARVN | Arvinas, Inc. | 423.03M | -4.15% | 1,108,445 | 275.30M |
| 470 | PRTA | Prothena Corporation plc | 422.10M | -2.14% | 861,946 | 52.74M |
| 471 | SI | Shoulder Innovations, Inc. | 421.59M | -0.79% | 166,353 | 64.49M |
| 472 | CRMD | CorMedix Inc. | 419.16M | 3.74% | 3,609,755 | 412.49M |
| 473 | OVID | Ovid Therapeutics Inc. | 415.21M | -5.98% | 2,833,645 | 1.45M |
| 474 | RZLT | Rezolute, Inc. | 411.22M | -6.67% | 2,478,408 | - |
| 475 | SRTA | Strata Critical Medical, Inc. | 407.30M | -5.59% | 1,125,742 | 280.76M |
| 476 | TECX | Tectonic Therapeutic, Inc. | 405.26M | -1.47% | 268,769 | - |
| 477 | TVGN | Tevogen Inc. | 405.20M | -6.35% | 9,329 | - |
| 478 | CADL | Candel Therapeutics, Inc. | 395.37M | -1.75% | 1,727,102 | - |
| 479 | MOBI | Mobia Medical, Inc. | 394.94M | -0.08% | 186,049 | 51.89M |
| 480 | EPRX | Eupraxia Pharmaceuticals Inc. | 391.72M | -5.23% | 361,642 | - |
| 481 | AVTX | Avalo Therapeutics, Inc. | 390.88M | 0.15% | 1,179,818 | 59.00K |
| 482 | IRD | Opus Genetics, Inc. | 385.65M | -2.21% | 1,187,138 | 7.91M |
| 483 | PHAT | Phathom Pharmaceuticals, Inc. | 378.82M | -8.27% | 1,330,402 | 274.88M |
| 484 | CERS | Cerus Corporation | 373.62M | -2.63% | 4,512,960 | 226.57M |
| 485 | PBYI | Puma Biotechnology, Inc. | 364.47M | -0.98% | 861,208 | 231.83M |
| 486 | ASPE | Aspen Neuroscience, Inc. | 361.16M | 0.24% | 130,038 | - |
| 487 | BWAY | BrainsWay Ltd. | 361.00M | -2.86% | 109,517 | 65.33M |
| 488 | MASS | 908 Devices Inc. | 360.52M | -7.47% | 477,461 | 65.79M |
| 489 | ALEC | Alector, Inc. | 347.63M | 1.52% | 1,953,024 | 173.47M |
| 490 | YDES | YD Bio Limited | 342.12M | 5.92% | 29,790 | 1.24M |
| 491 | EMBC | Embecta Corp. | 341.09M | -2.75% | 862,806 | 1.02B |
| 492 | CTNM | Contineum Therapeutics, Inc. | 340.83M | -3.98% | 369,211 | - |
| 493 | LYEL | Lyell Immunopharma, Inc. | 339.28M | 1.62% | 171,085 | 15.00K |
| 494 | MPLT | MapLight Therapeutics, Inc. | 333.87M | -7.48% | 357,916 | - |
| 495 | PRLD | Prelude Therapeutics Incorporated | 333.54M | -0.77% | 300,079 | 21.57M |
| 496 | LRMR | Larimar Therapeutics, Inc. | 330.12M | -2.48% | 1,707,224 | - |
| 497 | INO | Inovio Pharmaceuticals, Inc. | 329.66M | 2.92% | 7,920,895 | 298.90K |
| 498 | CV | CapsoVision, Inc. | 327.56M | -3.17% | 178,619 | 13.92M |
| 499 | CCCC | C4 Therapeutics, Inc. | 325.67M | 1.64% | 3,628,833 | 32.28M |
| 500 | VMD | Viemed Healthcare, Inc. | 322.85M | -1.05% | 258,854 | 310.37M |